These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809 [TBL] [Abstract][Full Text] [Related]
4. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478 [TBL] [Abstract][Full Text] [Related]
5. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759 [TBL] [Abstract][Full Text] [Related]
6. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma. Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376 [TBL] [Abstract][Full Text] [Related]
7. Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma. Nagao K; Yamaguchi S; Matsuyama H; Korenaga Y; Hirata H; Yoshihiro S; Fukunaga K; Oba K; Naito K Cancer Genet Cytogenet; 2005 Jul; 160(1):43-8. PubMed ID: 15949569 [TBL] [Abstract][Full Text] [Related]
8. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
9. Trisomy 3 in renal cell carcinoma. Renshaw AA; Fletcher JA Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cytogenetic analysis in clear cell renal carcinoma: a study on 131 patients with long-term follow-up. Antonelli A; Arrighi N; Tardanico R; Balzarini P; Zanotelli T; Corti S; Zani D; Cozzoli A; Cunico SC; Simeone C Anticancer Res; 2010 Nov; 30(11):4705-9. PubMed ID: 21115928 [TBL] [Abstract][Full Text] [Related]
11. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Klatte T; Pantuck AJ; Said JW; Seligson DB; Rao NP; LaRochelle JC; Shuch B; Zisman A; Kabbinavar FF; Belldegrun AS Clin Cancer Res; 2009 Feb; 15(4):1162-9. PubMed ID: 19228721 [TBL] [Abstract][Full Text] [Related]
12. Abnormalities of chromosome 5q correlate with morphologic features of better prognosis in clear cell renal carcinomas. Podolski J; Huzarski T; Byrski T; Tołoczko A; Wrzecion S; Sikorski A; Mahoy P; Huebner K; Rabbitts P; Lubiński J Pol J Pathol; 1995; 46(3):163-6. PubMed ID: 7496735 [TBL] [Abstract][Full Text] [Related]
13. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Moch H; Presti JC; Sauter G; Buchholz N; Jordan P; Mihatsch MJ; Waldman FM Cancer Res; 1996 Jan; 56(1):27-30. PubMed ID: 8548768 [TBL] [Abstract][Full Text] [Related]
14. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379 [TBL] [Abstract][Full Text] [Related]
16. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma. Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis. Sanjmyatav J; Schubert J; Junker K Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283 [TBL] [Abstract][Full Text] [Related]
18. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma. Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844 [TBL] [Abstract][Full Text] [Related]
19. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients. Lau LC; Tan PH; Chong TW; Foo KT; Yip S Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551 [TBL] [Abstract][Full Text] [Related]
20. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data. Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]